In vitro evaluation and pharmacokinetics in dogs of guar gum and Eudragit FS30D-coated colon-targeted pellets of indomethacin

Journal of Drug Targeting

Volumn 15, Issue 2, 2007, Pages 123-131

  Ji, Chongmin ^a   Xu, Huinan ^a   Wu, Wei ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA MANNOSIDASE; EUDRAGIT; GALACTOMANNANASE; GUAR GUM; INDOMETACIN; UNCLASSIFIED DRUG; DRUG CARRIER; GALACTAN; MANNAN; METHYLMETHACRYLATE METHACRYLIC ACID COPOLYMER; METHYLMETHACRYLATE-METHACRYLIC ACID COPOLYMER; NONSTEROID ANTIINFLAMMATORY AGENT; PLANT GUM; POLYMETHACRYLIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; COLON; CONTROLLED STUDY; DOG; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG PELLET; DRUG TARGETING; ENZYMATIC DEGRADATION; FILM COATING; IN VITRO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; MOLECULAR WEIGHT; NONHUMAN; PH; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; SLOW DRUG RELEASE; TIME TO MAXIMUM PLASMA CONCENTRATION; ANIMAL; DRUG SCREENING; METABOLISM; SCANNING ELECTRON MICROSCOPY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLON; DOGS; DRUG CARRIERS; DRUG EVALUATION, PRECLINICAL; GALACTANS; HYDROGEN-ION CONCENTRATION; INDOMETHACIN; MANNANS; MICROSCOPY, ELECTRON, SCANNING; PLANT GUMS; POLYMETHACRYLIC ACIDS;

EID: 34249745232     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860601143727     Document Type: Article

References (39)

1. Amighi, K., Timmermans, J., Puigdevall, J., Baltes, E. and Moes, AJ (1998) Peroral sustained-release film-coated pellets as a means to overcome physicochemical and biological drug-related problems. I. In vitro development and evaluation. Drug Dev Ind Pharm, 24, pp. 509-515.
2. Ashford, M., Fell, JT, Attwood, D. and Woodhead, PJ (1993) An in-vitro investigation into the suitability of pH dependent polymers for colonic targeting. Int J Pharm, 91, pp. 241-245.
3. Ashford, M., Fell, JT, Attwood, D., Sharma, H. and Woodhead, PJ (1993) An in vivo investigation into the suitability of pH-dependent polymers for colonic targeting. Int J Pharm, 95, pp. 193-199.
4. Basit, AW (2005) Advances in colonic drug delivery. Drugs, 65, pp. 1991-2007.
5. Bayliss, CE and Houston, AP (1986) Degradation of guar gum by faecal bacterial. Appl Environ Microbiol, 48, pp. 626-632.
6. Davis, SS, Wilding, EA and Wilding, IR (1993) Gastrointestinal transit of a matrix tablet formulation: Comparison of canine and human data. Int J Pharm, 94, pp. 235-238.
7. Durig, T. and Fassihi, R. (2002) Guar-based monolithic matrix systems: Effect of ionizable and non-ionizable substances and excipients on gel dynamics and release kinetics. J Control Release, 80, pp. 45-56.
8. Gao, C., Huang, J., Jiao, Y., Shan, L., Liu, Y. and Mei, X. (2006) In vitro release and in vivo absorption in beagle dogs of meloxicam from Eudragit® FS 30 D-coated pellets. Int J Pharm, 322, pp. 104-112.
9. Gliko-Kabir, I., Yagen, B., Penhasi, A. and Rubinstein, A. (1998) Low swelling, crosslinked guar and its potential use as colon-specific drug carrier. Pharm Res, 15, pp. 1019-1025.
10. Gliko-Kabir, I., Yagen, B., Baluom, M. and Rubinstein, A. (2000) Phosphated crosslinked guar for colon-specific drug delivery: II. In vitro and in vivo evaluation in the rat. J Control Release, 63, pp. 129-134.
11. Gupta, VK, Beckert, TE and Price, JC (2001) A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development. Int J Pharm, 213, pp. 83-91.
12. Ibekwe, VC, Fadda, HM, Parsons, GE and Basit, AW (2006) A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery. Int J Pharm, 308, pp. 52-60.
13. Ibekwe, VC, Liu, F., Fadda, HM, Khela, MK, Evans, DF, Parsons, GE and Basit, AW (2006) An investigation into the in vivo performance variability of pH responsive polymers for ileo-colonic drug delivery using gamma scintigraphy in humans. J Pharm Sci
14. (2006) A novel pH-, time- and enzyme-controlled colon-specific delivery system of 5-fluorouracil. Arch Pharm Res.
15. Krishnaiah, YSR, Styanarayana, S. and Prasad, YV Rama (1998) Evaluation of guar gum as a compression coat for drug targeting to colon. Int J Pharm, 171, pp. 137-146.
16. Krishnaiah, YSR, Raju, P Veer, Kumar, B Dinesh, Bhaskar, P. and Satyanarayana, V. (2001) Development of colon targeted drug delivery systems for mebendazole. J Control Release, 77, pp. 87-95.
17. Krishnaiah, YSR, Styanarayana, V., Kumar, B Dinesh and Karthikeyan, RS (2002) In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of indomethacin. Eur J Pharm Sci, 16, pp. 185-192.
18. Lee, WW, Wilson, CG and Mukherji, G. (2003) Time-dependent systems for colonic delivery. Modified-release drug delivery technology, pp. 243-248. Marcel Dekker, New York
19. Leong, CW, Newton, JM, Basit, AW, Podczeck, F., Cummings, JH and Ring, SG (2002) The formation of colonic digestible films of amylose and ethylcellulose from aqueous dispersions at temperatures below 37°C. Eur J Pharm Biopharm, 54, pp. 291-297.
20. Li, SP, Feld, KM and Kowarski, CR (1997) The effect of polymer coating systems on the preparation, tableting, and dissolution properties of sustained-release drug pellets. Drug Dev Ind Pharm, 23, pp. 623-631.
21. Matsuda, KI, Takaya, T., Shimoji, F., Muraoka, M., Yoshikawa, M. and Takada, K. (1996) Effect of food intake on the deliver of fluorescein as a model drug in colon delivery capsule after oral to beagle dogs. J Drug Target, 4, pp. 59-67.
22. Milojevic, S., Newton, JM, Cummings, JH, Gibson, GR, Botham, RL, Ring, SG, Stockham, M. and Allwood, MC (1996) Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using 5-aminosalicylic acid pellets. J Control Release, 38, pp. 75-84.
23. Mura, P., Maestrelli, F., Cirri, M., Rodríguez, ML González and Alvarez, AM Rabasco (2003) Development of enteric-coated pectin-based matrix tablets for colonic delivery of theophylline. J Drug Target, 11, pp. 365-371.
24. Nováková, L., Matysová, L., Havlíková, L. and Solich, P. (2005) Development and validation of HPLC method for determination of indomethacin and its two degradation products in topical gel. J Pharm Biomed Anal, 37, pp. 899-905.
25. Pozzi, F., Furlani, P., Gazzaniga, A., Davis, SS and Wilding, IR (1994) The Time-Clock ® system: A new oral dosage form for fast and complete release of drug after predetermined lag time. J Control Release, 31, pp. 99-108.
26. Prasad, YV Rama, Krishnaiah, YSR and Satyanarayana, S. (1998) In vitro evaluation of guar gum as a carrier for colon-specific drug delivery. J Control Release, 51, pp. 281-287.
27. Rubinstein, A., Radai, R., Ezra, M., Pathak, S. and Rokem, JS (1993) In vitro evaluation of calcium pectinate: A potential colon-specific drug delivery carrier. Pharm Res, 10, pp. 258-263.
28. Semdé, R., Amighi, K., Devleeschouwer, MJ and Moës, AJ (2000) Studies of pectin HM/Eudragit® RL/Eudragit® NE film-coating formulations intended for colonic drug delivery. Int J Pharm, 197, pp. 181-192.
29. Sinha, VR and Kumria, R. (2001) Polysaccharides in colon-specific drug delivery. Int J Pharm, 224, pp. 19-38.
30. Sugimoto M, Okagaki T, Narisawa S, Koida Y, Nakajima K. 1998. Improvement of dissoluteion characteristics and bioavailability of poorly water-soluble drugs by novel cogrinding method using water-soluble polymer. Int J Pharm 160:11-19.
31. Tomlin, J., Read, NW, Edwards, CA and Duerden, BI (1986) The degradation of guar gum by a faecal incubation system. Br J Nutr, 55, pp. 481-486.
32. Tozaki, H., Komoike, J., Tada, C., Maruyama, T., Terabe, A., Suzuki, T., Yamamoto, A. and Muranishi, S. (1997) Chitosan capsules for colon-specific drug delivery: Improvement of insulin absorption from the rat colon. J Pharm Sci, 86, pp. 1016-1021.
33. Tugcu-Demiröz, F., Acartürk, F., Takka, S. and Konus-Boyunaga, Ö (2004) In-vitro and in-vivo evaluation of mesalazine-guar gum matrix tablets for colonic drug delivery. J Drug Target, 12, pp. 105-112.
34. Turkoglu, M. and Ugurlu, T. (2002) In vitro evaluation of pectin-HPMC compression coated 5-aminosalicylic acid tablets for colonic delivery. Eur J Pharm Biopharm, 53, pp. 65-73.
35. Mooter, G Van den (2006) Colon drug delivery. Expert Opin Drug Deliv, 3, pp. 111-125.
36. Wakerly, Z., Felt, J., Attwood, D. and Parkins, D. (1996) Pectin/ ethylcellulose film coating formulations for colonic drug delivery. Pharm Res, 13, pp. 1210-1212.
37. Watts, PJ, Barrow, L., Streed, KP, Wilson, CG, Spiller, RC, Melia, CD and Davies, MC (1992) The transit rate of different-sized model dosage forms through the human colon and the effects of a lactulose-induced catharsis. Int J Pharm, 87, pp. 215-221.
38. Wilson, PJ and Basit, AW (2005) Exploiting gastrointestinal bacteria to target drugs to the colon: An in vitro study using amylose coated tablets. Int J Pharm, 300, pp. 89-94.
39. Wong, D., Larrabee, S., Clifford, K., Tremblay, J. and Friend, DR (1997) USP dissolution apparatus III (reciprocating cylinder) for screening of guar-based colonic delivery formulations. J Control Release, 47, pp. 173-179.